Fabrication and integration of a low-cost 3D printing-based glucose biosensor for bioprinted liver-on-a-chip

In the last two decades, significant progress has been made in the development of more physiologically relevant organ-on-a-chip (OOC) systems that can mimic tissue microenvironments. Despite the advantages of these microphysiological systems, such as portability, ability to mimic physiological flow conditions, and reduction of the number of reagents required for preparation and detection, they lack real-time analyte detection with high accuracy. To address this limitation, biosensor technologies have been integrated with OOC systems to facilitate simultaneous analysis of different analytes with a single device. However, the integration of biosensors with OOC systems is challenging because of the competing demands of low-cost, simple fabrication processes and speed. In this study, we fabricate a glucose-sensing device and integrate it with a liver-on-a-chip (LOC) platform. A carbon black-polylactic acid-based three-electrode system was printed using fused deposit molding 3D printing technology to simplify the fabrication process. The sensitivity of the fabricated glucose biosensing device was enhanced by coating the electrodes with multi-walled carbon nanotubes. A biosensing integration study performed using a perfusion-based LOC demonstrated the stability, biocompatibility, and sensitivity of the proposed glucose sensing device. Furthermore, drug-toxicity studies conducted using the LOC platform demonstrated the ability of the device to detect a broad range of glucose concentrations and its enhanced sensitivity. Schematic diagram illustrating the fabrication and integration of a low-cost 3D printing-based glucose biosensor for a bioprinted liver-on-a-chip (LOC). In this research, a glucose-sensing device was made and integrated into a liver-on-a-chip system. A 3D-printed carbon black-polylactic acid electrode setup was used, and carbon nanotubes were added for increased sensitivity. Testing on a perfusion-based LOC showcased stability, biocompatibility, and sensitivity, including drug-toxicity studies for various glucose levels.image